Health Canada is advising NOT to use Tequin (gatifloxacin) in patients with diabetes

Health Canada is advising NOT to use Tequin (gatifloxacin) in patients with diabetes.

In January, we told you about the many reports of hyper- and hypoglycemia associated with Tequin...especially in diabetes patients.

Health Canada is now saying that Tequin shouldn't be used at all in diabetes patients...and that they are still reviewing more data.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter Canada includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 300+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get quote